Screening and Monitoring for Anemia in Semaglutide Users Screening and monitoring for anemia in individuals using semaglutide are essential for early detection and prevention of potential complications
On peut conclure que le smaglutide, en maintenant la concentration en insuline, hypoglycmiante, et en baissant celle du glucagon, hyperglycmiant, contribue faire baisser globalement la glycmie
A part of Watch Medier Senior Safety Manager Pharmacokineticist, PK/PD Modelling & Simulation Clinical Supply Manager Medical Writer responsible for Clinical Disclosure Global Clinical Lead, Clinical Development, Migraine & Pain Director, Drug Safety Operations You need to be a subscriber to read the rest of the article
10.2337/db21-0154 50
In fact, in October 2025, Eli Lillys Mounjaro (Tirzepatide) achieved a historic milestone by becoming the highest-selling pharmaceutical brand in India by value for that month, racking up Rs 100 crore in monthly sales
This may be related to the formulation vehicle rather than the semaglutide itself